These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28164648)

  • 1. Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.
    Janek D; Slavik L; Ulehlova J; Krcova V; Hlusi A; Prochazkova J
    Clin Lab; 2016 Jul; 62(7):1309-1315. PubMed ID: 28164648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS; Schouwers S; Devreese KM
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2024 Aug; 22(8):2345-2362. PubMed ID: 38704123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F; Persijn L; Decavele AS; Devreese K
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of anticardiolipin and antiβ2 glycoprotein I antibodies using a new automated chemiluminescent assay: superior thrombotic prediction of combined results measured by two different methods.
    Chung Y; Kim JE; Lim HS; Kim HK
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):10-5. PubMed ID: 24158115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort.
    Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    Front Immunol; 2021; 12():648881. PubMed ID: 34276646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system.
    Devreese KM; Poncet A; Lindhoff-Last E; Musial J; de Moerloose P; Fontana P
    J Thromb Haemost; 2017 Jan; 15(1):91-95. PubMed ID: 27813343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of IgA antiphospholipid antibodies in diagnosis of the antiphospholipid syndrome].
    Yang B; Zhao JL; Huang ZC; Su ZZ; Li MT; Zeng XF; Hu CJ
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3404-3410. PubMed ID: 34758544
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.
    Zhang S; Wu Z; Li P; Bai Y; Zhang F; Li Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2059. PubMed ID: 26579816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Chayoua W; de Laat B; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2022 Feb; 20(2):508-524. PubMed ID: 34758192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
    Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML;
    Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.